Trial intelligence / Profile preview

Long-term safety and maintenance of normonatremia with satavaptan in dilutional hyponatremia

2006-005422-23Phase 3Completed

Sponsor
Sanofi
Start
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of satavaptan in Hyperhydration and hyponatraemia, sponsored by Sanofi. Started Apr 2007; status: completed.

02

Drugs

satavaptan
03

Conditions

Hyperhydrationhyponatraemia

Beyond the preview

Go deeper on 2006-005422-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005422-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call